Disparities in uptake of direct-acting antiviral therapy for hepatitis C among people who inject drugs in a Canadian setting.
M Eugenia SocíasLianping TiEvan WoodEkaterina NosovaMark HullKanna HayashiKora DebeckMichael John MilloyPublished in: Liver international : official journal of the International Association for the Study of the Liver (2019)
Despite increases in HCV treatment uptake among PWID after the introduction of DAAs in our setting, disparities in access remain. Social-structural and behavioural barriers to HCV care should be addressed for the success of any HCV elimination strategy.